Publications

MABs are recommended by both the National Institutes of Health and the Infectious Diseases Society of America for treatment of COVID-19 in ambulatory patients with mild or moderate COVID-19 with high risk for clinical progression.

 

Descriptions of novel approaches to promote MAB administration are needed. One strategy implemented by our health system is partnership with community integrated paramedics (CIP) to promote home MAB administration. This cohort study describes our experience and how this strategy may factor into associated outcomes.